BOSTON - March 11, 2021 - Ahead of the conference, SMi Group caught up with Lynne Ensor, Vice President, RCS Head of Global Compliance, Parexel International, to discuss and hear about her expertise in the pharmaceutical microbiology industry, as a chair of the conference what she's looking forward to at this year's conference, what vital topics she'll be addressing in her presentation.
Interested parties can register at US$499 for pharmaceutical and biotechnology companies and US$999 for commercial organizations at http://www.microbiologyeastcoast.com/PR4.
Lynne Ensor exclusive interview snippets are:
The pharmaceutical microbiology industry has matured significantly in previous years, what key developments have you witnessed in the last year within the field?
'The swift response to the COVID-19 pandemic has been impressive this past year! Technological advances already in development were quickly adapted to be used to detect or combat SARS-CoV-2, such as mRNA vaccines. Pivoting innovation streamlined the development and allowed people access to tests, therapies, and vaccines in response to the pandemic in record time, which was and remains desperately needed. These historic achievements required critical global industry collaborations and regulatory flexibility to allow for quick pivoting to assist in warding off the spread and mutation rate of SARS-CoV-2.
What is the greatest challenge for you to personally overcome within the pharmaceutical microbiology field currently?
'Related to the COVID-19 pandemic, I think the greatest challenge over the past year, and which continues, is remaining current on scientifically-sound, data-driven information and attempting to inform others of it. There has been so much unsubstantiated information spread making it challenging to aid in the understanding of the science and logic behind mitigating the transmission of the virus and the seriousness of our current situation.
The full chair interview is available in the 'download centre' at http://www.microbiologyeastcoast.com/PR4.
As well as chairing the conference, Lynne Ensor will also give an esteemed presentation on the following:
'Emergency Use Authorization: Understanding a Regulatory Strategy Weapon Used to Battle a Pandemic'
The full speaker line-up, brochure and agenda are available on http://www.microbiologyeastcoast.com/PR4.
Proudly Sponsored by: bioMérieux and Microcoat
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
SMi's 4th Annual Pharmaceutical Microbiology East Coast
Virtual Conference: Online Access Only
Conference: April 28 – 29, 2021
Workshops: April 27, 2021
http://www.microbiologyeastcoast.com/PR4
#SMiPharmaMicroEC
Contact
SMi Group
Simi Sapal
